The downregulation of CALM2, a calcium binding protein responsible for proliferation, apoptosis, and cell cycle development [30], as a consequence of BC200 overexpression, may in part explain the phenotypic changes observed in these breast cancer subtypes. This evidence concerns the gene CALM2 and breast cancer.